Date published: 2025-11-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

BJAB nuclear extract: sc-2145

0.0(0)
Write a reviewAsk a question

Datasheets
  • supplied in four vials, each containing 250 µg nuclear extract in 50 µl buffer
  • provided in 20 mM HEPES (pH 7.9), 20% v/v glycerol, 0.1 M KCI, 0.2 mM EDTA, 0.5 mM PMSF and 0.5 mM DTT
  • human nuclear extract; B cell lymphoma cells
  • suitable for use in Gel Shift and Western Blotting assays
  • Extracts should be stored at -70°C and repeated freezing and thawing should be avoided.
  • prepared by the method of Dignam et al., (1983) Nucleic Acids Res. 11: 1475

QUICK LINKS

SEE ALSO...

The BJAB nuclear extract is derived from the BJAB cell line, a well-established model originating from a Burkitt's lymphoma, which is a type of non-Hodgkin's lymphoma. This cell line is composed of B lymphocytes and is frequently used to study B-cell physiology and the underlying mechanisms of lymphoma. The nuclear extract from BJAB cells contains a rich variety of nuclear proteins, including transcription factors, regulatory proteins, and chromatin-associated proteins that are crucial for understanding the gene regulatory networks within lymphocytes. Researchers utilize BJAB nuclear extracts to delve into the nuclear dynamics that govern B-cell behavior, particularly focusing on aspects like transcriptional regulation, DNA replication, and response to cellular stress. By examining these extracts, scientists can gain insights into the normal and pathological states of B cells, exploring how alterations in nuclear components can influence lymphoma progression. The BJAB nuclear extract has been instrumental in studies aimed at understanding the complex interactions within the nuclei of lymphoma cells, leading to a better understanding of gene expression patterns, signaling pathways, and the regulation of cell cycle and apoptosis in B lymphocytes.

BJAB nuclear extract References:

  1. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function.  |  O′Sullivan, BJ., et al. 2000. Proc Natl Acad Sci U S A. 97: 11421-6. PMID: 11027342
  2. Kaposi′s sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.  |  Ballestas, ME. and Kaye, KM. 2001. J Virol. 75: 3250-8. PMID: 11238851
  3. The latency-associated nuclear antigen of Kaposi′s sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter.  |  Knight, JS., et al. 2001. J Biol Chem. 276: 22971-8. PMID: 11313352
  4. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi′s sarcoma-associated herpesvirus.  |  Garber, AC., et al. 2001. J Virol. 75: 7882-92. PMID: 11483733
  5. Direct association of Bloom′s syndrome gene product with the human mismatch repair protein MLH1.  |  Pedrazzi, G., et al. 2001. Nucleic Acids Res. 29: 4378-86. PMID: 11691925
  6. Differential expression of HLA class II genes associated with disease susceptibility and progression in rheumatoid arthritis.  |  Heldt, C., et al. 2003. Arthritis Rheum. 48: 2779-87. PMID: 14558083
  7. Latency-associated nuclear antigen of Kaposi′s sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1.  |  Verma, SC., et al. 2004. J Virol. 78: 10348-59. PMID: 15367601
  8. Latency-associated nuclear antigen (LANA) of Kaposi′s sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.  |  Verma, SC., et al. 2006. J Virol. 80: 2243-56. PMID: 16474132
  9. Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors.  |  Choudhuri, T., et al. 2006. Virology. 351: 58-72. PMID: 16631833
  10. Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer.  |  Lin, D., et al. 2007. Mol Cancer. 6: 23. PMID: 17386101
  11. Interaction of Epstein-Barr viral (EBV) origin of replication (oriP) with EBNA-1 and cellular anti-EBNA-1 proteins.  |  Wen, LT., et al. 1990. Virology. 178: 293-6. PMID: 2167556
  12. Induction of anti-EBNA-1 protein by 12-O-tetradecanoylphorbol-13-acetate treatment of human lymphoblastoid cells.  |  Wen, LT., et al. 1989. J Virol. 63: 3315-22. PMID: 2545906
  13. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.  |  Johannsen, E., et al. 1995. J Virol. 69: 253-62. PMID: 7983717
  14. E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development.  |  Jacobs, Y., et al. 1993. Mol Cell Biol. 13: 7321-33. PMID: 8246953

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

BJAB nuclear extract

sc-2145
250 µg/0.05 ml
$160.00